According to our latest research, the global dyslipidemia drugs market size reached USD 14.2 billion in 2024, reflecting robust demand driven by the increasing prevalence of lipid disorders worldwide. The market is projected to expand at a CAGR of 6.1% from 2025 to 2033, with the total value expected to reach USD 24.1 billion by 2033. This steady growth is underpinned by a combination of rising cardiovascular disease incidence, ongoing innovation in lipid-lowering therapies, and heightened awareness of preventive healthcare.
https://growthmarketreports.co....m/report/dyslipidaem
처럼
논평
공유하다
